ArticleOncology letters2025

Efficacy and safety of different angiogenesis inhibitors combined with PARP inhibitors in the treatment of ovarian cancer: A systematic review and meta‑analysis.

Xuemei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.